# 1. Financial Performance ## A. Key Figures * **Revenue Growth:** **9%** Q4 FY26 vs Q3 FY26 (Sequential) · **-6%** FY26 vs FY25 (Full Year) * **Employee Costs:** **₹14 Cr** FY26 Increase (Full Year) ## B. Revenue & Margin Analysis * **Sequential Recovery:** Strong quarter-on-quarter top-line growth driven by balanced performance across both Essentials and Specialties segments. * **Full-Year Headwinds:** Annual revenue contraction attributed to a deflationary feedstock environment, margin pressures, and one-time structural impacts in Specialties. * **Profitability Trajectory:** Sequential margin expansion across both business units in Q4 establishes a constructive baseline for FY27. ## C. Operational & Capital Strategy * **Cost Drivers:** Rising personnel expenses reflect the commencement of operations at new sites and the normalization of one-time reversals from the prior year. * **Strategic Investment:** Significant capital deployment at the Dahej site spans both business segments, funded by a stable balance sheet and prudent working capital management. --- # 2. Segment & Product Performance ## A. Key Figures * **Fluorination Revenue Utilization:** **40% to 45%** of peak capacity achieved in FY '26 * **Ethyl Acetate (ETAC) Spreads:** **$100** (Baseline) · **$130** (Jan/Feb) · **$220** (March) · **$250** (April) ## B. Specialties Recovery * **Contract Dynamics:** Top-line contraction was primarily driven by the loss of a structural product representing **10%** of revenue, alongside a specific large contract exit. * **Sequential Rebound:** The segment demonstrated a robust Q4 recovery, recouping earlier losses through the activation of an alternative product pipeline and the realization of deferred shipments. * **Resilient Pricing:** Management maintained a nearly flat year-on-year performance in core areas by engaging in responsible pricing discussions and proactive contract management. ## C. Fluorination & Order Book * **Operational Scaling:** The Lote fluorination facility successfully met its utilization targets for the fiscal year, signaling a transition from ramp-up to steady-state contribution. * **Forward Visibility:** The business enters the new financial year with a strong order book, providing clear revenue visibility for the fluorination portfolio. ## D. End-Market Demand * **Late-Quarter Surge:** Pharma and Printing & Packaging sectors saw stable demand early in the quarter followed by a significant volume spike in March. * **Industrial Firming:** Demand within Industrial Solutions is showing signs of strengthening, with positive momentum carrying over into the start of **Q1 FY27**. * **Spread Expansion:** Essentials profitability is poised for improvement following a dramatic escalation in ETAC spreads, which more than doubled between February and April. --- # 3. Capacity & Project Execution ## A. Project Timelines & Execution * **Dahej Phase 2 Roadmap:** Chemical charging is slated for **Q1 FY27**, with meaningful P&L contribution expected in **H2 FY27** following a necessary qualification phase. * **Hitachi Contract Momentum:** Project manifestation is scheduled for **Q3**, supported by a **multi-year contract** and a steady ramp-up through **FY27**. * **Lote Facility Activation:** A new world-scale ethyl acetate line has commenced operations, with customer dispatches already in progress. ## B. Strategic Outlook & Utilization * **Product Mix Evolution:** Future revenue growth at Dahej will be driven by the introduction of **ketene and diketene** elements in the second half of the next fiscal year. * **Asset Efficiency:** Management maintains its original asset turnover targets for the Dahej project across both the Specialties and Essentials divisions. --- # 4. Supply Chain & Operations ## A. Key Figures * **Acetic Acid Pricing:** **$300–$320** unsustainable lows · **$350–$370** Q3 settlement · **$400+** Q3 peak · **$700+** March/April spike * **Logistics Costs:** **2x** increase (100% growth) due to Middle East crisis ## B. Feedstock Price Volatility * **Extreme Input Volatility:** Acetic acid experienced severe price swings and supply disruptions starting in **March 2026**, driven by global supplier shutdowns and unsustainable pricing floors. * **Relative Feedstock Stability:** In contrast to the volatile acetic acid market, ethanol prices sourced from the Americas have remained firm and stable. ## C. Logistics & Freight * **Geopolitical Headwinds:** Regional conflicts in the Middle East have reversed early FY26 improvements in vessel availability, causing freight costs to surge and creating a significant operational drag. ## D. Procurement & Digitization * **Strategic Mitigation:** Internal procurement strategies successfully ensured consistent asset utilization and supply reliability despite the turbulent raw material environment. * **Digital Transformation:** The enterprise-wide supply chain digitization project remains on track, with a scheduled go-live date in **Q2 FY '27**. --- # 5. Organizational & Strategic Updates ## A. Leadership Appointments * **C-Suite Transition:** Mr. Amit Jain has been appointed as the new **Chief Financial Officer**, effective **June 16, 2026**. * **Strategic Hire:** The incoming CFO brings **30 years of experience** across the chemicals, packaging, and pharmaceutical sectors, joining from **Gharda Chemicals**. ## B. Customer & Inventory Strategy * **Market Positioning:** Management utilized FY26 as a foundational year, prioritizing customer proximity and operational levers to drive growth in **FY27 and beyond**. * **Bifurcated Demand Patterns:** Client behavior remains split between risk-averse inventory building to ensure supply reliability and a cautious just-in-time restocking approach. ## C. Operational Efficiency * **Sustainability Gains:** Year-on-year improvements achieved in water and energy intensity across existing facilities, with full disclosures pending in the **BRSR report**. --- # 6. Risks & Chemical Market Factors ## A. Key Figures * **Feedstock Price Change:** **-30%** Acetic Acid (2-year deflationary trend) * **Product Spreads:** **$100 to $110** Ethyl Acetate (Q3 FY '26) ## B. Feedstock Price Dynamics * **Deflationary Headwinds:** Significant multi-year price erosion in key feedstocks necessitated price adjustments within the Specialties segment, impacting overall sales realization. * **Price Flooring:** Management indicates acetic acid prices may have bottomed out, supported by high methanol costs, though geopolitical instability remains a primary risk to stability. ## C. Geopolitical & Macroeconomic Volatility * **Supply Chain Disruptions:** Conflict in the Middle East has triggered volatility in critical building blocks, specifically **crude oil and methanol**, affecting flows into Asia. * **Ecosystem Uncertainty:** Macroeconomic instability and regional conflicts starting in **late February 2026** have caused sudden spikes in feedstock costs, complicating the broader chemical market outlook. * **Spread Monitoring:** Current market inquiries are focused on the resilience of ethyl acetate margins in the face of ongoing Middle Eastern supply chain pressures. --- # 7. Guidance & Outlook ## A. Key Figures * **Acetic Acid Price:** **$450–$470** Current range/Anticipated floor * **ETAC Spreads:** **$150–$160** Current range (Historical Avg: **$220**) ## B. FY27 Revenue Ramp-up * **Capacity Utilization:** Management anticipates a gradual ramp-up of new capacities through **FY '28 and beyond**, signaling a recovery from recent order deferments. * **Market Stabilization:** Outlook assumes a move past historical volatility in feedstock pricing and supply chain disruptions. ## C. Pricing Floor Expectations * **Feedstock Normalization:** Acetic acid prices have moderated following short-lived spikes caused by Middle East methanol supply anxiety. * **Spread Recovery Potential:** Current ETAC spreads remain significantly compressed, trading well below the long-term **12-to-13-year** historical average.